Real World Evidence on the Effectiveness of Nusinersen within the National Program to Treat Spinal Muscular Atrophy in Poland.
Dominika KrupaMarcin CzechEwa ChudzyńskaBeata KońMaria JędrzejowskaPublished in: Healthcare (Basel, Switzerland) (2023)
The drug program to treat SMA improved patient care in Poland. The NHF database was a reliable source to monitor resource-intensive therapies' costs, demography, and selected patient outcomes.